Meta-Analysis Shows Similar Risk of Thrombosis After Drug-Eluting Stent, Bare-Metal Stent, or Angioplasty

REFERENCES

• Ardissino D., Cavallini C., Bramucci E., Indolfi C., Marzocchi A., Manari A., Angeloni G., Carosio G., Bonizzoni E., Colusso S., Repetto M., Merlini P. A. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: A randomized trial. Journal of the American Medical Association 2004; 292: 2727–2734
   PubMed Web of Science ®Google Scholar
• Bavry A. A., Bhatt D. L. Acute myocardial infarction and drug-eluting stents: A green light for their use or time for measured restraint?. American Heart Journal 2007; 153: 719–721
   PubMed Web of Science ®Google Scholar
• Bavry A. A., Kumbhani D. J., Helton T. J., Bhatt D. L. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: A meta-analysis. Journal of the American College of Cardiology 2005; 45: 941–946
   PubMed Web of Science ®Google Scholar
• Bavry A. A., Kumbhani D. J., Helton T. J., Borek P. P., Mood G. R., Bhatt D. L. Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. American Journal of Medicine 2006; 119: 1056–1061
   PubMed Web of Science ®Google Scholar
• Carlsson J., von Wagenheim B., Linder R., Anwari T. M., Qvist J., Petersson I., Magounakis T., Lagerqvist B. Is late stent thrombosis in drug-eluting stents a real clinical issue?: A single-center experience and review of the literature. Clinical Research in Cardiology 2007; 96: 86–93
   PubMed Web of Science ®Google Scholar
• Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M E. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788–794
   PubMed Web of Science ®Google Scholar
• Costa R. A., Lansky A. J., Mintz G. S., Mehran R., Tsuchiya Y., Negoita M., Gilutz Y., Nikolsky E., Fahy M., Pop R., Cristea E., Carlier S., Dangas G., Stone G. W., Leon M. B., Muller R., Techen G., Grube E. Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). American Journal of Cardiology 2005; 95: 113–116
   PubMed Web of Science ®Google Scholar
• Custodis F., Scheller B., Laufs U. [Stable coronary artery disease—case report]. Deutsch Medizinische Wochenschrift 2006; 131: 554–555
   PubMed Web of Science ®Google Scholar
• Cutlip D. E., Windecker S., Mehran R., Boam A., Cohen D. J., van Es G. A., Steg P. G., Morel M. A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M. W., Serruys P. W. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344–2351
   PubMed Web of Science ®Google Scholar
• Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Vaina S., Morger C., Kukreja N., Juni P., Sianos G., Hellige G., Van Domburg R. T., Hess O. M., Boersma E., Meier B., Windecker S., Serruys P. W. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667–678
   PubMed Web of Science ®Google Scholar
• Dawkins K. D., Grube E., Guagliumi G., Banning A. P., Zmudka K., Colombo A., Thuesen L., Hauptman K., Marco J., Wijns W., Popma J. J., Koglin J., Russell M. E. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: Support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005; 112: 3306–3313
   PubMed Web of Science ®Google Scholar
• Egger M., Davey S. G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997a; 315: 629–634
   PubMed Web of Science ®Google Scholar
• Egger M., Smith G. D. Meta-analysis. Potentials and promise. British Medical Journal 1997; 315: 1371–1374
   PubMed Web of Science ®Google Scholar
• Egger M., Smith G. D., Phillips A. N. Meta-analysis: Principles and procedures. British Medical Journal 1997b; 315: 1533–1537
   PubMed Web of Science ®Google Scholar
• Ellis S. G., Colombo A., Grube E., Popma J., Koglin J., Dawkins K. D., Stone G. W. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: A TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. Journal of the American College of Cardiology 2007; 49: 1043–1051
   PubMed Web of Science ®Google Scholar
• Erbel R., Haude M., Hopp H. W., Franzen D., Rupprecht H. J., Heublein B., Fischer K., de Jaegere P., Serruys P., Rutsch W., Probst P. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. New England Journal of Medicine 1998; 339: 1672–1678
   PubMed Web of Science ®Google Scholar
• Fajadet J., Wijns W., Laarman G. J., Kuck K. H., Ormiston J., Munzel T., Popma J. J., Fitzgerald P. J., Bonan R., Kuntz R E. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial. Minerva Cardioangiology 2007; 55: 1–18
   PubMedGoogle Scholar
• Gershlick A., De S. I., Chevalier B., Stephens-Lloyd A., Camenzind E., Vrints C., Reifart N., Missault L., Goy J. J., Brinker J. A., Raizner A. E., Urban P., Heldman A. W. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: The European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation 2004; 109: 487–493
   PubMed Web of Science ®Google Scholar
• Grines C. L., Cox D. A., Stone G. W., Garcia E., Mattos L. A., Giambartolomei A., Brodie B. R., Madonna O., Eijgelshoven M., Lansky A. J., O'Neill W. W., Morice M. C. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. New England Journal of Medicine 1999; 341: 1949–1956
   PubMed Web of Science ®Google Scholar
• Grube E., Silber S., Hauptmann K. E., Mueller R., Buellesfeld L., Gerckens U., Russell M. E. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003; 107: 38–42
   PubMed Web of Science ®Google Scholar
• Hong M. K., Mintz G S, Tinana A., Lee C. W., Kim J. J., Fearnot N. E., Park S. W., Park S. J., Weissman N. J. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: A serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 2003; 108(11)1295–1298
   PubMed Web of Science ®Google Scholar
• Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G. M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. Journal of the American Medical Association 2005; 293: 2126–2130
   PubMed Web of Science ®Google Scholar
• Joner M., Finn A. V., Farb A., Mont E. K., Kolodgie F. D., Ladich E., Kutys R., Skorija K., Gold H. K., Virmani R. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. Journal of the American College of Cardiology 2006a; 48: 193–20
   PubMed Web of Science ®Google Scholar
• Kaiser C., Brunner-La Rocca H. P., Buser P. T., Bonetti P. O., Osswald S., Linka A., Bernheim A., Zutter A., Zellweger M., Grize L., Pfisterer M. E. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet 2005; 366: 921–929
   PubMed Web of Science ®Google Scholar
• Karvouni E., Korovesis S., Katritsis D. G. Very late thrombosis after implantation of sirolimus eluting stent. Heart 2005; 91: e45
   PubMedGoogle Scholar
• Kastrati A., Mehilli J., Nekolla S., Bollwein H., Martinoff S., Pache J., Schuhlen H., Seyfarth M., Gawaz M., Neumann F. J., Dirschinger J., Schwaiger M., Schomig A. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. Journal of the American College of Cardiology 2004; 43: 734–741
   PubMed Web of Science ®Google Scholar
• Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabate M., Suttorp M. J., Baumgart D., Seyfarth M., Pfisterer M. E., Schomig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. New England Journal of Medicine 2007; 356: 1030–103
   PubMed Web of Science ®Google Scholar
• Kelbaek H., Thuesen L., Helqvist S., Klovgaard L., Jorgensen E., Aljabbari S., Saunamaki K., Krusell L. R., Jensen G. V., Botker H. E., Lassen J. F., Andersen H. R., Thayssen P., Galloe A., van Weert A. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial. Journal of the American College of Cardiology 2006; 47: 449–455
   PubMed Web of Science ®Google Scholar
• Lansky A. J., Costa R. A., Mintz G. S., Tsuchiya Y., Midei M., Cox D. A., O'Shaughnessy C., Applegate R. A., Cannon L. A., Mooney M., Farah A., Tannenbaum M. A., Yakubov S., Kereiakes D. J., Wong S. C., Kaplan B., Cristea E., Stone G. W., Leon M. B., Knopf W. D., O'Neill W. W. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: Angiographic follow-up of the DELIVER clinical trial. Circulation 2004; 109: 1948–1954
   PubMed Web of Science ®Google Scholar
• Liistro F., Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001; 86: 262–264
   PubMed Web of Science ®Google Scholar
• Manjappa N., Agarwal A., Cavusoglu E. Very late bare-metal stent thrombosis. A case report and review of the literature. Journal of Invasive Cardiology 2006; 18: E203–E206
   PubMedGoogle Scholar
• McFadden E. P., Stabile E., Regar E., Cheneau E., Ong A. T., Kinnaird T., Suddath W. O., Weissman N. J., Torguson R., Kent K. M., Pichard A. D., Satler L. F., Waksman R., Serruys P. W. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519–1521
   PubMed Web of Science ®Google Scholar
• Morice M. C., Serruys P. W., Sousa J. E., Fajadet J., Ban H. E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New England Journal of Medicine 2002; 346: 1773–1780
   PubMed Web of Science ®Google Scholar
• Moses J. W., Leon M. B., Popma J. J., Fitzgerald P. J., Holmes D. R., O'Shaughnessy C., Caputo R. P., Kereiakes D. J., Williams D. O., Teirstein P. S., Jaeger J. L., Kuntz R. E. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. New England Journal of Medicine 2003; 349: 1315–1323
   PubMed Web of Science ®Google Scholar
• Ong A. T., McFadden, Regar E., de Jaegere P. P., Van Domburg R. T., Serruys P. W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. Journal of the American College of Cardiology 2005; 45: 2088–2092
   PubMed Web of Science ®Google Scholar
• Pache J., Dibra A., Mehilli J., Dirschinger J., Schomig A., Kastrati A. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: A prospective, randomized trial. European Heart Journal 2005; 26: 1262–1268
   PubMed Web of Science ®Google Scholar
• Pasceri V., Patti G., Speciale G., Pristipino C., Richichi G., Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. American Heart Journal 2007; 153: 749–754
   PubMed Web of Science ®Google Scholar
• Pfisterer M., Brunner-La Rocca H. P., Buser P. T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. Journal of American College of Cardiology 2006; 48: 2584–2591
   PubMed Web of Science ®Google Scholar
• Rabbat M. G., Bavry A. A., Bhatt D. L., Ellis S. G. Understanding and minimizing late thrombosis of drug-eluting stents. Cleveland Clinic Journal of Medicine 2007; 74: 129–136
   PubMed Web of Science ®Google Scholar
• Sabate M., Jimenez-Quevedo P., Angiolillo D. J., Gomez-Hospital J. A., Alfonso F., Hernandez-Antolin R., Goicolea J., Banuelos C., Escaned J., Moreno R., Fernandez C., Fernandez-Aviles F., Macaya C. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112: 2175–2183
   PubMed Web of Science ®Google Scholar
• Saito S., Hosokawa G., Tanaka S., Nakamura S. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: Final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. PASTA Trial Investigators. Catheter Cardiovascular Intervention 1999; 48: 262–268
   PubMed Web of Science ®Google Scholar
• Schampaert E., Cohen E. A., Schluter M., Reeves F., Traboulsi M., Title L. M., Kuntz R. E., Popma J. J. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). Journal of the American College of Cardiology 2004; 43: 1110–1115
   PubMed Web of Science ®Google Scholar
• Scheller B., Hehrlein C., Bocksch W., Rutsch W., Haghi D., Dietz U., Bohm M., Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. New England Journal of Medicine 2006; 355: 2113–2124
   PubMed Web of Science ®Google Scholar
• Scheller B., Speck U., Abramjuk C., Bernhardt U., Bohm M., Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004; 110: 810–814
   PubMed Web of Science ®Google Scholar
• Schofer J., Schluter M., Gershlick A. H., Wijns W., Garcia E., Schampaert E., Breithardt G. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093–1099
   PubMed Web of Science ®Google Scholar
• Sousa J. E., Costa M. A., Abizaid A., Abizaid A. S., Feres F., Pinto I. M., Seixas A. C., Staico R., Mattos L. A., Sousa A. G., Falotico R., Jaeger J., Popma J. J., Serruys P. W. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192–195
   PubMed Web of Science ®Google Scholar
• Spaulding C., Daemen J., Boersma E., Cutlip D. E., Serruys P. W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. New England Journal of Medicine 2007; 356: 989–997
   PubMed Web of Science ®Google Scholar
• Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrie D., Slama M. S., Merkely B., Erglis A., Margheri M., Varenne O., Cebrian A., Stoll H. P., Snead D. B., Bode C. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. New England Journal of Medicine 2006; 355: 1093–1104
   PubMed Web of Science ®Google Scholar
• Steinberg D. H., Mishra S., Javaid A., Slottow T. L., Buch A. N., Roy P., Okabe T., Smith K. A., Torguson R., Xue Z., Pichard A. D., Satler L. F., Kent K. M., Suddath W. O., Waksman R. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or = 3.5 mm) coronary arteries. American Journal of Cardiology 2007; 99: 599–602
   PubMed Web of Science ®Google Scholar
• Stettler C., Wandel S., Allemann S., Kastrati A., Morice M. C., Schomig A., Pfisterer M. E., Stone G. W., Leon M. B., de Lezo J. S., Goy J. J., Park S. J., Sabate M., Suttorp M. J., Kelbaek H., Spaulding C., Menichelli M., Vermeersch P., Dirksen M. T., Cervinka P., Petronio A. S., Nordmann A. J., Diem P., Meier B., Zwahlen M., Reichenbach S., Trelle S., Windecker S., Juni P. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007; 370: 937–948
   PubMed Web of Science ®Google Scholar
• Stone G. W., Ellis S. G., Colombo A., Dawkins K. D., Grube E., Cutlip D. E., Friedman M., Baim D. S., Koglin J. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 2007a; 115: 2842–2847
   PubMed Web of Science ®Google Scholar
• Stone G. W., Ellis S. G., Cox D. A., Hermiller J., O'Shaughnessy C., Mann J. T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J. J., Russell M. E. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. New England Journal of Medicine 2004; 350: 221–231
   PubMed Web of Science ®Google Scholar
• Stone G. W., Grines C. L., Cox D. A., Garcia E., Tcheng J. E., Griffin J. J., Guagliumi G., Stuckey T., Turco M., Carroll J. D., Rutherford B. D., Lansky A. J. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. New England Journal of Medicine 2002; 346: 957–966
   PubMed Web of Science ®Google Scholar
• Suryapranata H., De Luca G., 't Hof A. W., Ottervanger J. P., Hoorntje J. C., Dambrink J. H., Gosselink A. T., Zijlstra F., de Boer M. J. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart 2005; 91: 641–645
   PubMed Web of Science ®Google Scholar
• Suryapranata H., 't Hof A. W., Hoorntje J. C., de Boer M. J., Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502–2505
   PubMed Web of Science ®Google Scholar
• Suttorp M. J., Laarmann G. J., Rahel B. M., Kelder J. C., Bosschaert M. A., Kiemeneij F., Ten Berg J. M., Bal E. T., Rensing B. J., Eefting F. D., Mast E. G. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 2006; 114(9)921–928
   PubMed Web of Science ®Google Scholar
• Svilaas T., van der Horst L. C., Zijlstra F. A quantitative estimate of bare-metal stenting compared with balloon angioplasty in patients with acute myocardial infarction: Angiographic measures in relation to clinical outcome. Heart 2007; 93: 792–800
   PubMed Web of Science ®Google Scholar
• Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., Mihalcsik L., Tespili M., Valsecchi O., Kolodgie F. D. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?. Circulation 2004; 109: 701–705
   PubMed Web of Science ®Google Scholar
• Wenaweser P., Hess O. Stent thrombosis is associated with an impaired response to antiplatelet therapy. Journal of the American College of Cardiology 2005; 46: CS5–CS6
   PubMedGoogle Scholar